Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
View corrected article
CorrectionsFull Access

Corrections

Published Online:1 Aug 2009https://doi.org/10.1176/appi.ajp.2009.166.8.942

In the Editorial “Last Observation Carried Forward Versus Mixed Models in the Analysis of Psychiatric Clinical Trials,” by Robert M. Hamer, Ph.D., and Pippa M. Simpson, Ph.D. (Am J Psychiatry 2009; 166:639–641), it was stated that the mixed model analysis of the data reported in the article “Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia” appears in a data supplement. This analysis appeared in the published article itself.